NDC 16571-657
Cevimeline Hydrochloride
Cevimeline Hydrochloride
Cevimeline Hydrochloride is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Rising Pharmaceuticals, Inc.. The primary component is Cevimeline Hydrochloride.
Product ID | 16571-657_75781c14-f302-4751-843e-5832c25c9538 |
NDC | 16571-657 |
Product Type | Human Prescription Drug |
Proprietary Name | Cevimeline Hydrochloride |
Generic Name | Cevimeline Hydrochloride |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2014-06-17 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA203775 |
Labeler Name | Rising Pharmaceuticals, Inc. |
Substance Name | CEVIMELINE HYDROCHLORIDE |
Active Ingredient Strength | 30 mg/1 |
Pharm Classes | Cholinergic Muscarinic Agonists [MoA],Cholinergic Receptor Agonist [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |